A New Study Supports the Prognostic Value of the Pca3 Prostate …
Friday, October 10th, 2008( TSX : CUR), a life sciences company commercializing high-value cancer diagnostic tests and delivering laboratory services, reported today that PCA3, the Company’s highly specific prostate cancer marker, is featured in an important …
[Continue Reading]